Update on Seborrheic Keratosis: Optimizing Patient Outcomes
WebcastFaculty
OVERVIEW
Update on Seborrheic Keratosis: Optimizing Patient Outcomes is organized by Global Academy For Medical Education and will be held Sep 01, 2017 - Sep 30, 2018.
The target audience for this medical event is dermatologists, pediatricians, family practitioners, internists, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients and practice medical or aesthetic dermatology. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Seborrheic keratosis (SK) is a common and benign skin lesion that affects more than 80 million Americans. Medical intervention is not required unless the diagnosis is uncertain and a biopsy is indicated, or unless the SKs are symptomatic (pruritus, irritation, or bleeding). Still, many patients seek medical advice because of cosmetic issues or concerns about the possibly malignant nature of the lesions. Current treatment modalities involve tissue destruction, which poses a risk for scarring, hyper- or hypopigmentation, or other unwanted sequelae. Future treatments may offer a topical approach that reduces the risk of unacceptable outcomes. Clinicians should be able to diagnose SK accurately and efficiently and should be aware of current and emerging treatment strategies.
Learning Objectives:
By reading and studying this supplement, participants should be better able to
• Differentiate seborrheic keratosis (SK) from other skin lesions
• Describecurrentandemergingtreatmentoptions for SK
• Matchpatientswiththemostappropriateinterventions for effective removal of SKs, including those in cosmetically sensitive areas, such as the face and neck
Additional details will be posted as soon as they are available.
The target audience for this medical event is dermatologists, pediatricians, family practitioners, internists, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients and practice medical or aesthetic dermatology. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Seborrheic keratosis (SK) is a common and benign skin lesion that affects more than 80 million Americans. Medical intervention is not required unless the diagnosis is uncertain and a biopsy is indicated, or unless the SKs are symptomatic (pruritus, irritation, or bleeding). Still, many patients seek medical advice because of cosmetic issues or concerns about the possibly malignant nature of the lesions. Current treatment modalities involve tissue destruction, which poses a risk for scarring, hyper- or hypopigmentation, or other unwanted sequelae. Future treatments may offer a topical approach that reduces the risk of unacceptable outcomes. Clinicians should be able to diagnose SK accurately and efficiently and should be aware of current and emerging treatment strategies.
Learning Objectives:
By reading and studying this supplement, participants should be better able to
• Differentiate seborrheic keratosis (SK) from other skin lesions
• Describecurrentandemergingtreatmentoptions for SK
• Matchpatientswiththemostappropriateinterventions for effective removal of SKs, including those in cosmetically sensitive areas, such as the face and neck
Additional details will be posted as soon as they are available.
SPECIALITIES
DermatologyRELATED ONLINE COURSES
Quick Links